These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1673041

  • 1. [Neuroleptic malignant syndrome].
    Sczesni B, Schröder J, Becker H, Przuntek H.
    Wien Klin Wochenschr; 1991; 103(1):1-7. PubMed ID: 1673041
    [Abstract] [Full Text] [Related]

  • 2. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M, Kornhuber J.
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [Abstract] [Full Text] [Related]

  • 3. The neuroleptic malignant syndrome.
    Smego RA, Durack DT.
    Arch Intern Med; 1982 Jun; 142(6):1183-5. PubMed ID: 6124221
    [Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome, syndrome malin].
    Takahashi A, Todoroki J, Murasaki M.
    Nihon Rinsho; 1996 Mar; 54(3):839-44. PubMed ID: 8904246
    [Abstract] [Full Text] [Related]

  • 5. The neuroleptic malignant syndrome--a review.
    Gibb WR, Lees AJ.
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH.
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [Abstract] [Full Text] [Related]

  • 7. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M, Lamberti P, Simone F, Iliceto G, Federico F, Ferrari E.
    Funct Neurol; 1991 Aug; 6(3):285-8. PubMed ID: 1683852
    [Abstract] [Full Text] [Related]

  • 8. Intravenous lisuride in the treatment of the neuroleptic malignant syndrome.
    Sczesni B, Bittkau S, von Baumgarten F, von Schröder J, Suchy I, Przuntek H.
    J Clin Psychopharmacol; 1991 Jun; 11(3):185-8. PubMed ID: 2066456
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome.
    McHugh TP.
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 12. Therapy of neuroleptic malignant syndrome.
    Lazarus A.
    Psychiatr Dev; 1986 Apr; 4(1):19-30. PubMed ID: 3703852
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.